echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > J Neurol Neurosurg Psychiatry: Laxam can be effective and safe as an adjuvant therapy for primary tonic-clonic seizures

    J Neurol Neurosurg Psychiatry: Laxam can be effective and safe as an adjuvant therapy for primary tonic-clonic seizures

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Idiopathic systemicmedsci.


    medsci.


    The study included 242 patients with IGE and PGTCS taking 1-3 anti-epileptic drugs at the same time.


     

    The patients were randomly assigned and received ≥1 dose of the trial drug (lacosamide/placebo: n=121/n=121).


     

    During the 24-week treatment period, the second PGTCS risk of lacosamide was significantly lower than that of placebo (Kaplan-Meier survival estimate was 55.


    In summary, the results of the study show that Laxam is effective and safe as an adjuvant treatment for uncontrolled PGTCS in IGE patients.


     

    Original source:

     

    David G Vossler, et al.


    ncbi.
    nlm.
    nih.
    gov/32817358/" target="_blank" rel="noopener">Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.